InsiderSignal.AI

InsiderSignal.ai

VRTX - Vertex Pharmaceuticals Inc / Ma

Insider Purchase by Sachs Bruce I (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Sachs Bruce I, serving as Dir at Vertex Pharmaceuticals Inc / Ma (VRTX), purchased 5,000 shares at $389.68 per share, for a total transaction value of $1,948,416.00. Following this transaction, Sachs Bruce I now holds 45,000 shares of VRTX.

This purchase represents a 13.00% increase in Sachs Bruce I's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, August 7, 2025, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Sachs Bruce I

Dir

# Bruce I. Sachs Bruce I. Sachs, age 65, is the Lead Independent Director at Vertex Pharmaceuticals Inc. (VRTX), serving as an independent director since 1998 and in the lead role since 2011.[[1]](https://fintool.com/app/research/companies/VRTX/people/bruce-sachs) He chairs the Management Development & Compensation Committee (MDCC) and serves on the Corporate Governance & Nominating Committee (CGNC), providing oversight on executive compensation, board composition, and risk management.[[1]](https://fintool.com/app/research/companies/VRTX/people/bruce-sachs) Sachs is Partner Emeritus at Charles River Ventures (CRV), a venture capital firm founded in 1970, following over 20 years as General Partner, including more than 10 years as Managing Partner.[[1]](https://fintool.com/app/research/companies/VRTX/people/bruce-sachs)[[2]](https://www.insidearbitrage.com/2025/08/the-return-of-two-briefcases-bruce-insider-weekends/) His executive career includes CEO roles at Stratus Computer (1997–1998) and Xylogics (1993–1995), and senior positions at Ascend Communications (EVP & GM, 1998–1999) and Bay Networks (EVP & GM, 1995–1997).[[1]](https://fintool.com/app/research/companies/VRTX/people/bruce-sachs) He holds a BSEE from Bucknell University, MEE from Cornell University, and MBA from Northeastern University.[[1]](https://fintool.com/app/research/companies/VRTX/people/bruce-sachs) Sachs has board experience with companies like Nantero, Inc., SpiderCloud Wireless, and others in technology and biotech sectors.[[3]](https://www.marketscreener.com/insider/BRUCE-SACHS-A02O32/)

View full insider profile →

Trade Price

$389.68

Quantity

5,000

Total Value

$1,948,416.00

Shares Owned

45,000

Trade Date

Wednesday, August 6, 2025

200 days ago

SEC Filing Date

Thursday, August 7, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Vertex Pharmaceuticals Inc / Ma

Company Overview

No company information available
View news mentioning VRTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/111229

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime